Status:

COMPLETED

Serum Pro-Diabetes Inflammation Biomarkers in Patients With Apical Periodontitis.

Lead Sponsor:

University of Turin, Italy

Conditions:

Apical Periodontitis

Insulin Resistance

Eligibility:

All Genders

25-55 years

Brief Summary

Inflammation is a common factor of chronic periodontitis and diabetes. However, to date, there is no scientific evidence supporting a causal effect of the inflammation created by apical periodontitis ...

Detailed Description

Healthy, consenting and informed patients of both gender under 55 years of age with apical periodontitis will be enrolled as cases. Healthy, consenting and informed patients of both gender under 55 ye...

Eligibility Criteria

Inclusion

  • 25-55 years, healthy

Exclusion

  • under 25 years, over 55 years, patients with systemic or oral diseases or patients who underwent other dental treatments in the previous 6 months

Key Trial Info

Start Date :

February 9 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 25 2023

Estimated Enrollment :

27 Patients enrolled

Trial Details

Trial ID

NCT04824209

Start Date

February 9 2021

End Date

April 25 2023

Last Update

April 28 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Department of Oncology - University of Turin

Turin, Italy, 10126

2

Endodontics, Department of Surgical Sciences - Univeristy of Turin

Turin, Italy, 10126

Serum Pro-Diabetes Inflammation Biomarkers in Patients With Apical Periodontitis. | DecenTrialz